Literature DB >> 3531958

Argon laser photocoagulation for macular edema in branch vein occlusion.

D Finkelstein.   

Abstract

The Branch Vein Occlusion Study is a multicenter, randomized controlled clinical trial that was designed to answer several questions regarding the management of complications of branch vein occlusion. Recently, this study reported the benefit of argon laser photocoagulation for improving visual acuity in certain eyes with macular edema, performing the laser photocoagulation in a "grid" pattern over the area demonstrated as leaking by fluorescein angiography. Comparing treated patients with control patients (mean follow-up 3.1 years for all study eyes), a gain of at least two lines of visual acuity from baseline maintained for two consecutive visits was significantly greater in treated eyes (P = 0.00049 log rank test). Because of this improvement in visual acuity with argon laser photocoagulation, the study recommends laser photocoagulation for patients with macular edema associated with branch vein occlusion who meet the eligibility criteria of the study.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3531958     DOI: 10.1016/s0161-6420(86)33651-0

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  9 in total

1.  Ultrastructure and hemodynamics of microaneurysms in retinal vein occlusion examined by an offset pinhole adaptive optics scanning light ophthalmoscope.

Authors:  Shin Kadomoto; Yuki Muraoka; Akihito Uji; Ryosuke Tamiya; Sotaro Ooto; Tomoaki Murakami; Yasuyuki Oritani; Kentaro Kawai; Akitaka Tsujikawa
Journal:  Biomed Opt Express       Date:  2020-10-05       Impact factor: 3.732

2.  Evaluation of ultrasound-assisted thrombolysis using custom liposomes in a model of retinal vein occlusion.

Authors:  Walid F Abdallah; Hitenkumar Patel; Edward G Grant; Bruno Diniz; Gerald J Chader; Mark S Humayun
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-10-05       Impact factor: 4.799

3.  Dexamethasone Intravitreal Implant for Early Treatment and Retreatment of Macular Edema Related to Branch Retinal Vein Occlusion: The Multicenter COBALT Study.

Authors:  Young Hee Yoon; Jong Woo Kim; Joo Yong Lee; In Taek Kim; Se Woong Kang; Hyeong Gon Yu; Hyoung Jun Koh; Sung Soo Kim; Dong-Jin Chang; Susan Simonyi
Journal:  Ophthalmologica       Date:  2018-04-11       Impact factor: 3.250

4.  Ocular microcirculation changes, measured with laser speckle flowgraphy and optical coherence tomography angiography, in branch retinal vein occlusion with macular edema treated by ranibizumab.

Authors:  Toshifumi Asano; Hiroshi Kunikata; Masayuki Yasuda; Koji M Nishiguchi; Toshiaki Abe; Toru Nakazawa
Journal:  Int Ophthalmol       Date:  2020-09-07       Impact factor: 2.031

Review 5.  Comparative efficacy and safety of approved treatments for macular oedema secondary to branch retinal vein occlusion: a network meta-analysis.

Authors:  Stephane A Regnier; Michael Larsen; Vladimir Bezlyak; Felicity Allen
Journal:  BMJ Open       Date:  2015-06-05       Impact factor: 2.692

6.  Comparison between Ozurdex and intravitreal anti-vascular endothelial growth factor treatment for retinal vein occlusion-related macular edema: A systematic review and meta-analysis of randomized controlled trials.

Authors:  Qiuming Hu; Haoyu Li; Wenhua Xu; Yi Du; Chao Ma; Jianfeng He
Journal:  Indian J Ophthalmol       Date:  2019-11       Impact factor: 1.848

7.  Dexamethasone Intravitreal Implant for the Treatment of Macular Edema Following Retinal Vein Occlusion: Post Hoc Analysis of Post-Marketing Surveillance Data in the Real-World Setting in Korea.

Authors:  Min Seok Kim; Jasmine Choi; Hyeong Du Lee; Se Joon Woo
Journal:  Clin Ophthalmol       Date:  2021-08-27

8.  Use of intravitreal triamcinolone in the treatment of macular edema related to retinal vein occlusion.

Authors:  Ashish Sharma; Baruch D Kuppermann; M Cristina Kenney
Journal:  Open Ophthalmol J       Date:  2008-04-07

Review 9.  Branch retinal vein occlusion: pathogenesis, visual prognosis, and treatment modalities.

Authors:  Jiri Rehak; Matus Rehak
Journal:  Curr Eye Res       Date:  2008-02       Impact factor: 2.424

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.